COPLEY NEW VP-SCIENTIFIC AFFAIRS IS FORMER FDAer SKELLY
This article was originally published in The Tan Sheet
Executive Summary
COPLEY NEW VP-SCIENTIFIC AFFAIRS IS FORMER FDAer SKELLY, who will "direct the company's regulatory affairs, research and product development programs," the Canton, Mass.-based generic drug company announced Nov. 9. Jerome Skelly, PhD, spent 20 years with FDA, most recently as deputy director for the Center for Drug Evaluation & Research's Office of Research Resources, where, Copley said, he was responsible for "developing and improving systems and procedures for verifying data submitted to FDA," Copley said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning